3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Melanoma
3
Breast Neoplasms
2
Thymic aplasia
1
Small Cell Lung Carcinoma
1
Pain, Postoperative
1
Neoplasms
1
Lung Neoplasms
1
Immunologic Deficiency Syndromes
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
3
Carboplatin
3
trilaciclib
2
tislelizumab
2
anlotinib
2
Etoposide
2
nintedanib
1
Topotecan
1
Tobacco Use Cessation Devices
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Gene Expression Profiling
1
Early Intervention, Educational
1
Counseling
1
Bupropion
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Small Cell Lung Carcinoma
×
Blood Specimen Collection
×
Clear all
NCT04180176
2024-01-17
PCG
Genentech, Inc.
Phase 4
Completed
945 enrolled